Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Repligen Corp (NASDAQ:RGEN)

32.13
Delayed Data
As of Feb 24
 -0.27 / -0.83%
Today’s Change
21.11
Today|||52-Week Range
34.06
+4.25%
Year-to-Date
No recent news for Repligen Corp.

Today’s Trading

Previous close32.40
Today’s open32.01
Day’s range31.41 - 32.32
Volume132,756
Average volume (3 months)237,343
Market cap$1.1B
Dividend yield--
Data as of 3:59pm ET, 02/24/2017

Growth & Valuation

Earnings growth (last year)+21.43%
Earnings growth (this year)--
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+25.14%
P/E ratio160.7
Price/Sales10.05
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ALDRAlder Biopharmaceuti...-0.13-0.57%
LOXOLoxo Oncology Inc-0.21-0.50%
XNCRXencor Inc-0.05-0.22%
IPXLImpax Laboratories I...-0.35-2.43%
Data as of 3:59pm ET, 02/24/2017

Financials

Last reporting dateFebruary 22, 2017
EPS forecast (this quarter)$0.07
Annual revenue (last year)$104.5M
Annual profit (last year)$11.7M
Net profit margin11.17%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Tony J. Hunt
Vice President-
Global Operations
Steve Curran
Corporate headquarters
Waltham, Massachusetts

Forecasts


Search for Jobs